(Q71961918)
Statements
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial (English)
T E Witzig
L Letendre
J Gerstner
G Schroeder
J A Mailliard
G Colon-Otero
R F Marschke